Bradley Porter
Overview
Explore the profile of Bradley Porter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuhair M, Keene D, Panagopoulos D, Malcolme-Lawes L, Porter B, Kanagaratnam P, et al.
Arrhythm Electrophysiol Rev
. 2025 Feb;
14:e01.
PMID: 39981423
Vasovagal syncope (VVS) is the most common cause of syncope, and significantly impacts quality of life despite its benign nature. For some patients, conventional management strategies such as lifestyle changes,...
2.
Gorenek B, Wijnmaalen A, Goette A, Mert G, Porter B, Gustafsson F, et al.
Europace
. 2024 Sep;
26(10).
PMID: 39270731
Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. During AHF, there is...
3.
Mannakkara N, Khan I, Ghazanfar A, Wijesuriya N, Mehta V, de Vere F, et al.
J Cardiovasc Electrophysiol
. 2024 Aug;
35(10):2039-2052.
PMID: 39136365
Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide and remains a major cause of morbidity and mortality. Unfortunately, a significant proportion of patients have persistent AF, for which...
4.
Kaza N, Sorbini M, Liu Z, Johal M, Porter B, Nowbar A, et al.
Open Heart
. 2024 Jun;
11(1).
PMID: 38890128
Background: Neurocardiogenic syncope is a common condition with significant associated psychological and physical morbidity. The effectiveness of therapeutic options for neurocardiogenic syncope beyond placebo remains uncertain. Methods: The primary endpoint...
5.
Reddy R, Howard J, Ahmad Y, Shun-Shin M, Simader F, Miyazawa A, et al.
Arrhythm Electrophysiol Rev
. 2023 Dec;
12:e26.
PMID: 38124803
Background: The prognostic impact of ventricular tachycardia (VT) catheter ablation is an important outstanding research question. We undertook a reconstructed individual patient data meta-analysis of randomised controlled trials comparing ablation...
6.
Sidhu B, Lee A, Gould J, Porter B, Sieniewicz B, Elliott M, et al.
Heart Rhythm
. 2023 Jul;
20(11):1481-1488.
PMID: 37453603
Background: The WiSE-CRT System (EBR systems, Sunnyvale, CA) permits leadless left ventricular pacing. Currently, no intraprocedural guidance is used to target optimal electrode placement while simultaneously guiding acoustic transmitter placement...
7.
Dawood T, Chen C, Sidhu B, Ruijsink B, Gould J, Porter B, et al.
Med Image Anal
. 2023 Jun;
88:102861.
PMID: 37327613
Quantifying uncertainty of predictions has been identified as one way to develop more trustworthy artificial intelligence (AI) models beyond conventional reporting of performance metrics. When considering their role in a...
8.
Coyle C, Koutsoftidis S, Kim M, Porter B, Keene D, Luther V, et al.
J Interv Card Electrophysiol
. 2023 Mar;
PMID: 36867371
Background: Ablation of autonomic ectopy-triggering ganglionated plexuses (ET-GP) has been used to treat paroxysmal atrial fibrillation (AF). It is not known if ET-GP localisation is reproducible between different stimulators or...
9.
Kaza N, Htun V, Miyazawa A, Simader F, Porter B, Howard J, et al.
Europace
. 2022 Nov;
25(3):1077-1086.
PMID: 36352513
Guidelines recommend patients undergoing a first pacemaker implant who have even mild left ventricular (LV) impairment should receive biventricular or conduction system pacing (CSP). There is no corresponding recommendation for...
10.
Mannakkara N, Porter B, Child N, Sidhu B, Mehta V, Elliott M, et al.
Eur J Cardiothorac Surg
. 2022 Nov;
63(1).
PMID: 36346176
Objectives: Atrial fibrillation (AF) is common and can cause significant morbidity and detriment to quality of life. Success rates for conventional catheter ablation are suboptimal in persistent AF (PsAF), especially...